Loading provider…
Loading provider…
Surgery Physician in Tampa, FL
NPI: 1285640821Primary Employer
Moffitt Medical Group
moffitt.org
HQ Phone
Get MD Vernon's Phone Numberphone_androidMobile
Get MD Vernon's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
2004 - 2027
MI State Medical License
1987 - 2007

American Board of Surgery
Surgery
UCLA David Geffen School of Medicine/UCLA Medical Center
Internship • Surgery
1980 - 1987
Boston University School Of Medicine
bumc.bu.edu
Medical School
Until 1980
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 38900Lymph node imaging during surgery | 29 | 29 |
| 2 | 99205New patient office or other outpatient visit, typically 60 minutes | 29 | 29 |
| 3 | 38525Biopsy or removal of lymph nodes of under the arm, open procedure | 24 | 24 |
| 4 | 13121Repair of wound (2.6 to 7.5 centimeters) of scalp, arms, and/or legs | 20 | 20 |
| 5 | 11603Removal of malignant growth (2.1 to 3.0 centimeters) of the trunk, arms, or legs | 19 | 20 |
Unanswered questions about margin recommendations for primary cutaneous melanoma.
Authors: Wong, Joyce Y, Sondak, Vernon K
Innovations and challenges in melanoma: summary statement from the first Cambridge conference.
Authors: Patrick Hwu, Richard Essner, Michael Atkins
Journal: Clin Cancer Res
Authors: Hutchins, Laura F, Moon, James, Clark, Joseph I, Thompson, John A, Lange, Marianne K, Flaherty, Lawrence E, Sondak, Vernon K
Journal: Cancer
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: Regeneron Pharmaceuticals, Sanofi-Synthelabo
Intervention / Treatment: DRUG: Cemiplimab-Rwlc
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Collaborators: OncoSec Medical Incorporated
Intervention / Treatment: DRUG: Nivolumab, DEVICE: OncoSec Medical Electroporation Therapy System, DRUG: Tavo
Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Intervention / Treatment: DRUG: Optional 18F-FMISO PET scan (18F-fluoromisonidazole), PROCEDURE: Surgical Resection of Melanoma Metastases, DRUG: Pimonidazole hydrochloride (Hypoxyprobe™-1)